If you need support right now

This page includes language about suicide and self-harm, because that is how the trial's eligibility criteria are written. If reading it has been hard, you do not have to keep going. The services below are free, confidential, and answered by people trained for exactly this.

If you or someone else is in immediate danger, call 000.

  • Lifeline — 24/7 crisis support: 13 11 14
  • Suicide Call Back Service — 24/7 counselling: 1300 659 467
  • 13YARN — 24/7, for Aboriginal and Torres Strait Islander people: 13 92 76
  • Beyond Blue — 24/7 mental health support: 1300 22 4636
  • Emergency: 000

Outside Australia? The numbers above are Australian and will not work from overseas. Find a Helpline is a free directory of crisis lines in over 130 countries, run by ThroughLine with the International Association for Suicide Prevention. If you are in immediate danger, call your local emergency number.

Voxsanity is not a crisis service, and nothing on this page is medical advice. More Australian services are listed on our support lines page.

Phase 2 study for people with Crohn's Disease and Colitis

Recruiting Phase 2

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Phase 2
Sponsor Xencor, Inc.
Registry number NCT06619990
Started 10 October 2024 Today 16 October 2026 Estimated completion 1 December 2027

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
Xencor Investigative Site Adelaide SA Recruiting
Xencor Investigative Site Joondalup WA Completed
Xencor Investigative Site Melbourne VIC Recruiting
Xencor Investigative Site Nedlands WA Completed
Xencor Investigative Site South Brisbane QLD Recruiting
Xencor Investigative Site Southport QLD Recruiting
Xencor Investigative Site Wollongong NSW Recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 18 Years to 75 Years
Sex Anyone, regardless of sex
Healthy volunteers Accepted
Enrolment target 270

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

Parts A and B

* Age 18-55

* Must be in good health with no significant medical history

* Clinical laboratory values within normal range

* BMI 18-35 (inclusive)

* Contraceptive use by men or women consistent with local regulations

* Able and willing to provide written informed consent

Part C

* Age 18-75

* Must be in good health with no significant medical history

* UC diagnosis ≥ 3 months prior to screening

* Diagnosis of moderately to severely active UC as defined by a (MMS) ≥ 5, with a MES ≥ 2 and RBS ≥ 1

* Evidence of UC extending ≥ 15 cm from the anal verge, as determined by screening colonoscopy

* Must have inadequate response to, loss of response to, or intolerance to at least 1 of the conventional or advanced therapies of UC

* Able and willing to provide written informed consent

Exclusion Criteria:

Parts A and B

* Any physical or psychological condition that prohibits study completion

* History of suicidal behavior or suicidal ideation

* Heavy use of nicotine containing products

* HIV, hepatitis B and hepatitis C positive

* Cardiac arrhythmia, or clinically significant abnormal ECG

* Active use of prescription medications within 14 days of Day -1

* Active use of over-the-counter, or herbal medication within 7 days of Screening

* Other investigational products within 30 days

* Blood or plasma donation within 60 days

* Pregnant or breastfeeding

Part C

* Any physical or psychological condition that prohibits study participation

* Diagnosis of Crohn disease, indeterminate colitis, indeterminate colitis, microscopic colitis, ischemic colitis, infectious colitis, radiation colitis, and diverticular disease associated with colitis.

* Positive screen for Clostridium difficile (C. Difficile) toxins

* HIV, hepatitis B and hepatitis C positive

* Cardiac arrhythmia, or clinically significant abnormal ECG

* Pregnant or breastfeeding

Other protocol defined inclusion/exclusion criteria apply.

Dates on the record

Started 10 October 2024
Estimated completion 1 December 2027
Registry last updated 29 September 2026
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 29 September 2026.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.